S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q4 2024

Deep Track Capital

Periodo: Q4 2024 · Depositato: 2025-02-14
Vedi su SEC EDGAR
AUM
$2.68B
Valore totale del portafoglio
Posizioni
63
Titoli dichiarati
Prima Posizione
DVAX
8.5% $227.2M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-02-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
DVAXDYNAVAX TECHNOLOGIES CORP$227.2M8.47%
8.5%
GHGUARDANT HEALTH INC$196.1M7.31%$30.55$167.98+449.9%
7.3%
ITCIINTRA-CELLULAR THERAPIES INC$167.0M6.23%
6.2%
IMVTIMMUNOVANT INC$148.6M5.54%$24.77$38.79+56.6%
5.5%
APLSAPELLIS PHARMACEUTICALS INC$136.4M5.09%$31.91
5.1%
SWTXSPRINGWORKS THERAPEUTICS INC$125.0M4.66%
4.7%
CYTKCYTOKINETICS INC$117.6M4.39%$47.04$86.49+83.9%
4.4%
OCULOCULAR THERAPEUTIX INC$109.6M4.09%$8.54$9.64+12.9%
4.1%
VRDNVIRIDIAN THERAPEUTICS INC$86.7M3.23%$19.17$19.40+1.2%
3.2%
PLRXPLIANT THERAPEUTICS INC$78.7M2.93%$13.17$1.17-91.1%
2.9%
GPCRSTRUCTURE THERAPEUTICS INC$75.9M2.83%$27.12$53.45+97.1%
2.8%
IONSIONIS PHARMACEUTICALS INC$67.6M2.52%$34.96$81.80+134.0%
2.5%
NRIXNURIX THERAPEUTICS INC$56.5M2.11%$18.84$23.97+27.2%
2.1%
MBXMBX BIOSCIENCES INC$55.6M2.08%$18.43$57.80+213.6%
2.1%
ETNB89BIO INC$50.7M1.89%
1.9%
HRMYHARMONY BIOSCIENCES HLDGS IN$49.9M1.86%$34.41$37.26+8.3%
1.9%
DYNDYNE THERAPEUTICS INC$47.1M1.76%$23.56$23.07-2.1%
1.8%
SEPNSEPTERNA INC$43.8M1.63%$22.90$34.00+48.5%
1.6%
NMRANEUMORA THERAPEUTICS INC.$42.4M1.58%$10.60$1.67-84.3%
1.6%
GMABGENMAB A/S$41.7M1.56%$20.87$28.51+36.6%
1.6%
AKROAKERO THERAPEUTICS INC$41.5M1.55%
1.6%
VRNAVERONA PHARMA PLC$39.5M1.47%
1.5%
CLDXCELLDEX THERAPEUTICS INC NEW$38.9M1.45%$25.27$38.37+51.8%
1.4%
PTGXPROTAGONIST THERAPEUTICS INC$38.6M1.44%$38.60$131.62+241.0%
1.4%
ANIPANI PHARMACEUTICALS INC$35.9M1.34%$55.28$86.03+55.6%
1.3%
BCAXBICARA THERAPEUTICS INC$34.8M1.30%$17.42$29.00+66.5%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$33.4M1.25%$2.35$1.58-32.8%
1.3%
KRROKORRO BIO INC$33.3M1.24%$38.07$14.00-63.2%
1.2%
TERNTERNS PHARMACEUTICALS INC$30.9M1.15%$5.54
1.1%
ENGNENGENE HOLDINGS INC$30.3M1.13%$6.65$1.78-73.2%
1.1%

Attività Trimestre su Trimestre

Q4 2024 vs. Q3 2024

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
HRMYHARMONY BIOSCIENCES HLDGS IN$49.9M+8.3%
SEPNSEPTERNA INC$43.8M+48.5%
GMABGENMAB A/S$41.7M+36.6%
CLDXCELLDEX THERAPEUTICS INC NEW$38.9M+51.8%
PTGXPROTAGONIST THERAPEUTICS INC$38.6M+241.0%
RAREULTRAGENYX PHARMACEUTICAL IN$27.5M
BBIOBRIDGEBIO PHARMA INC$22.5M
LKFTGALAPAGOS NV$21.5M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ARGXARGENX SE$197.9M
NTLAINTELLIA THERAPEUTICS INC$101.7M
ALKSALKERMES PLC$98.0M
AXSMAXSOME THERAPEUTICS INC$77.0M
APGEAPOGEE THERAPEUTICS INC$58.7M
TGTXTG THERAPEUTICS INC$40.4M
KURAKURA ONCOLOGY INC$38.4M
KYMRKYMERA THERAPEUTICS INC$28.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NMRACALLNEUMORA THERAPEUTICS INC.$40.0M+2116.1%-84.3%
NMRACALLNEUMORA THERAPEUTICS INC.$34.9M+604.9%-84.3%
NMRACALLNEUMORA THERAPEUTICS INC.$10.2M+559.2%-84.3%
CYTKCYTOKINETICS INC$84.3M+296.9%+83.9%
BCAXBICARA THERAPEUTICS INC$14.5M+151.0%+66.5%
ETNB89BIO INC$30.2M+134.2%
GPCRSTRUCTURE THERAPEUTICS INC$22.4M+129.4%+97.1%
AKROAKERO THERAPEUTICS INC$21.7M+116.0%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
NKTRNEKTAR THERAPEUTICS$-18.9M-87.6%
FDMT4D MOLECULAR THERAPEUTICS IN$-40.9M-85.1%
SYRESPYRE THERAPEUTICS INC$-24.3M-78.1%
VRNAVERONA PHARMA PLC$-52.0M-73.3%
BCYCBICYCLE THERAPEUTICS PLC$-62.4M-64.0%
MNMDMIND MEDICINE MINDMED INC$-20.6M-60.1%
CLYMCLIMB BIO INC$-9.2M-52.0%
GERNGERON CORP$-20.2M-47.0%
Torna agli Hedge Fund